[Neutrophils and cancer: discovery of a new mechanism of cellular toxicity and therapeutic perspectives]
- PMID: 32014104
- DOI: 10.1051/medsci/2019262
[Neutrophils and cancer: discovery of a new mechanism of cellular toxicity and therapeutic perspectives]
References
-
- Treffers LW, Hiemstra IH, Kuijpers TW, et al. Neutrophils in cancer. Immunol Rev 2016; 273 : 312–328.
-
- Hernandez-Ilizaliturri FJ, Jupudy V, Ostberg J, et al. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin’s lymphoma severe combined immunodeficiency mouse model. Clin Cancer Res 2003; 9 : 5866–73.
-
- Li B Xu L Tao F et al. Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo. Oncotarget 2017 ; 8 : 39356–39366.
-
- Matlung HL, Babes L, Zhao XW, et al. Neutrophils kill antibody-opsonized cancer cells by trogoptosis. Cell Reports 2018; 23 : 3946–59.e6.
-
- Valgardsdottir R, Cattaneo I, Klein C, et al., Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies. Blood 2017; 129 : 2636–44.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical